Unknown

Dataset Information

0

Interferon-? regulates the proliferation and differentiation of mesenchymal stem cells via activation of indoleamine 2,3 dioxygenase (IDO).

ABSTRACT: The kynurenine pathway (KP) of tryptophan metabolism is linked to antimicrobial activity and modulation of immune responses but its role in stem cell biology is unknown. We show that human and mouse mesenchymal and neural stem cells (MSCs and NSCs) express the complete KP, including indoleamine 2,3 dioxygenase 1 (IDO) and IDO2, that it is highly regulated by type I (IFN-?) and II interferons (IFN-?), and that its transcriptional modulation depends on the type of interferon, cell type and species. IFN-? inhibited proliferation and altered human and mouse MSC neural, adipocytic and osteocytic differentiation via the activation of IDO. A functional KP present in MSCs, NSCs and perhaps other stem cell types offers novel therapeutic opportunities for optimisation of stem cell proliferation and differentiation.

SUBMITTER: Croitoru-Lamoury J 

PROVIDER: S-EPMC3040184 | biostudies-literature | 2011 Feb

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Interferon-γ regulates the proliferation and differentiation of mesenchymal stem cells via activation of indoleamine 2,3 dioxygenase (IDO).

Croitoru-Lamoury Juliana J   Lamoury Francois M J FM   Caristo Michael M   Suzuki Kazuo K   Walker David D   Takikawa Osamu O   Taylor Rosanne R   Brew Bruce J BJ  

PloS one 20110216 2

The kynurenine pathway (KP) of tryptophan metabolism is linked to antimicrobial activity and modulation of immune responses but its role in stem cell biology is unknown. We show that human and mouse mesenchymal and neural stem cells (MSCs and NSCs) express the complete KP, including indoleamine 2,3 dioxygenase 1 (IDO) and IDO2, that it is highly regulated by type I (IFN-β) and II interferons (IFN-γ), and that its transcriptional modulation depends on the type of interferon, cell type and species  ...[more]

Similar Datasets

Transcriptomics HeLa transcriptome induction by IFN gamma and indoleamine 2,3-dioxygenase (IDO)
2017-02-09 | GSE75956 | GEO
Unknown SOCS3 drives proteasomal degradation of indoleamine 2,3-dioxygenase (IDO) and antagonizes IDO-dependent tolerogenesis.
| S-EPMC2634889 | biostudies-literature
Unknown Indoleamine 2,3-dioxygenase (IDO)-1 and IDO-2 activity and severe course of COVID-19.
| S-EPMC8897979 | biostudies-literature
Unknown Indoleamine 2,3-dioxygenase (IDO) induced by Leishmania infection of human dendritic cells.
| S-EPMC3572781 | biostudies-literature
Transcriptomics Bruton’s tyrosine kinase (BTK) and indoleamine 2,3-dioxygenase (IDO) block differentiation of inflammatory dendritic cells in tumors
2021-08-25 | GSE180039 | GEO
Unknown Transcriptional regulation of indoleamine 2,3-dioxygenase (IDO) by tryptophan and its analogue : Down-regulation of the indoleamine 2,3-dioxygenase (IDO) transcription by tryptophan and its analogue.
| S-EPMC2267499 | biostudies-other
Unknown Indoleamine-2,3-dioxygenase (IDO) metabolic activity is detrimental for cervical cancer patient survival.
| S-EPMC4404792 | biostudies-literature
Genomics Bruton’s tyrosine kinase (BTK) and indoleamine 2,3-dioxygenase (IDO) block differentiation of inflammatory dendritic cells in tumors [ATAC-seq]
2021-08-25 | GSE180026 | GEO
Transcriptomics Bruton’s tyrosine kinase (BTK) and indoleamine 2,3-dioxygenase (IDO) block differentiation of inflammatory dendritic cells in tumors [scRNA-seq]
2021-08-25 | GSE180038 | GEO
Unknown A two-step induction of indoleamine 2,3 dioxygenase (IDO) activity during dendritic-cell maturation.
| S-EPMC1895261 | biostudies-literature